Felix Deanda

Author PubWeight™ 5.63^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes.	Antimicrob Agents Chemother	2011	1.68
2	Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.	Bioorg Med Chem Lett	2008	0.88
3	Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.	Bioorg Med Chem Lett	2009	0.83
4	Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.	Bioorg Med Chem Lett	2008	0.80
5	Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1.	J Med Chem	2008	0.80
6	Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase.	Bioorg Med Chem Lett	2008	0.75
7	Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats.	Bioorg Med Chem Lett	2011	0.75
8	Aza-stilbenes as potent and selective c-RAF inhibitors.	Bioorg Med Chem Lett	2006	0.75